Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Human Apotransferrin in Patients With β-thalassemia Intermedia
Conditions
Interventions
human apotransferrin
Locations
1
Netherlands
Academic Medical Centre
Amsterdam-Zuidoost, North Holland, Netherlands
Start Date
March 21, 2019
Primary Completion Date
March 31, 2022
Completion Date
March 31, 2022
Last Updated
August 15, 2022
Lead Sponsor
Prothya Biosolutions
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions